Logo

SNPTECH REPORTER SUBSCRIBERS: As Pharmacogenomics Matures In US, European Space Grapples for Traction

Mar 21, 2003

The pharmacogenomics wave does not seem to have hit European shores just yet: Venture capitalists there have a tepid interest in local SNP and pharmacogenomic startups, and companies there anxious about private-equity financing are in for a long, hot summer, most experts agree. It didn t have to be this way. Subscribe. (https://www.snptech.com/subscribe.htmtarget=_blank)

Breaking News
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.